Sanofi To Buy Biotech Firm, Synthorx For $2.5 Billion

Biotechnology firm headquartered in California, Synthorx is to be bought by France's Sanofi SA for a whooping sum of $2.5 billion. Sanofi agreed to the deal on Monday, December 9th, 2019...